Global Therapeutic Nuclear Medicines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

Table of Contents

1 Report Overview 1

• 1.1 Research Scope 1
• 1.2 Major Manufacturers Covered in This Report 2
• 1.3 Market Segment by Type 3
  • 1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 4
  • 1.3.2 Radium-223 5
  • 1.3.3 Lutetium-177 6
  • 1.3.4 Iodine-131 6
• 1.4 Market Segment by Application 7
  • 1.4.1 Global Therapeutic Nuclear Medicines Market Share by Application (2018-2025) 7
  • 1.4.2 Thyroid 8
  • 1.4.3 Bone Metastasis 9
  • 1.4.4 Lymphoma 9
• 1.5 Study Objectives 10
• 1.6 Years Considered 10

2 Global Growth Trends 12

• 2.1 Global Therapeutic Nuclear Medicines Market Size 12
  • 2.1.1 Global Therapeutic Nuclear Medicines Revenue 2013-2025 12
  • 2.1.2 Global Therapeutic Nuclear Medicines Sales 2013-2025 13
• 2.2 Therapeutic Nuclear Medicines Growth Rate by Regions 14
  • 2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions 2013-2018 14
  • 2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions 2013-2018 16
• 2.3 Industry Trends 17
  • 2.3.1 Market Top Trends 17
  • 2.3.2 Market Drivers 18

3 Market Share by Manufacturers 19

• 3.1 Therapeutic Nuclear Medicines Sales by Manufacturers 19
  • 3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers 2017-2018 19
  • 3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers 2017-2018 20
• 3.2 Revenue by Manufacturers 21
  • 3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2018) 21
  • 3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2013-2018) 22
  • 3.2.3 Global Therapeutic Nuclear Medicines Market Concentration Ratio 24
• 3.3 Therapeutic Nuclear Medicines Price by Manufacturers 24
• 3.4 Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution and Area Served 25
• 3.5 Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market 26
• 3.6 Key Manufacturers Therapeutic Nuclear Medicines Product Offered 26
• 3.7 Mergers & Acquisitions, Expansion Plans 27

4 Market Size by Type 30

• 4.1 Sales and Revenue for Each Type 30
  • 4.1.1 Radium-223 Sales and Revenue (2013-2018) 30
  • 4.1.2 Lutetium-177 Sales and Revenue (2013-2018) 30
  • 4.1.3 Iodine-131 Sales and Revenue (2013-2018) 30
• 4.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type 31
• 4.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type 33
• 4.4 Therapeutic Nuclear Medicines Price by Type 35

5 Market Size by Application 36

• 5.1 Overview 36
• 5.2 Global Therapeutic Nuclear Medicines Sales by Application 36

6 North America 38

• 6.1 North America Therapeutic Nuclear Medicines Breakdown Data by Company 39
• 6.2 North America Therapeutic Nuclear Medicines Breakdown Data by Type 40
• 6.3 North America Therapeutic Nuclear Medicines Breakdown Data by Application 42
• 6.4 North America Therapeutic Nuclear Medicines Breakdown Data by Countries 43
  • 6.4.1 North America Therapeutic Nuclear Medicines Sales by Countries 43
  • 6.4.2 North America Therapeutic Nuclear Medicines Revenue by Countries 44
  • 6.4.3 United States 46
  • 6.4.4 Canada 46
  • 6.4.5 Mexico 47

7 Europe 48

• 7.1 Europe Therapeutic Nuclear Medicines Breakdown Data by Company 49
• 7.2 Europe Therapeutic Nuclear Medicines Breakdown Data by Type 50
• 7.3 Europe Therapeutic Nuclear Medicines Breakdown Data by Application 51
• 7.4 Europe Therapeutic Nuclear Medicines Breakdown Data by Countries 53
  • 7.4.1 Europe Therapeutic Nuclear Medicines Sales by Countries 53
  • 7.4.2 Europe Therapeutic Nuclear Medicines Revenue by Countries 54
  • 7.4.3 Germany 56
  • 7.4.4 France 56
  • 7.4.5 UK 57
  • 7.4.6 Italy 57
  • 7.4.7 Russia 58

8 Asia Pacific 59

• 8.1 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Company 60
• 8.2 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Type 61
• 8.3 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Application 62
• 8.4 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Countries 64
  • 8.4.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Countries 64
  • 8.4.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries 64
  • 8.4.3 China 66
  • 8.4.4 Japan 67
  • 8.4.5 Korea 68
  • 8.4.6 India 69
  • 8.4.7 Southeast Asia 70

9 Central & South America 71

• 9.1 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Company 72
• 9.2 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Type 73
• 9.3 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Application 74
• 9.4 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Countries 76
  • 9.4.1 Central & South America Therapeutic Nuclear Medicines Sales by Countries 76
  • 9.4.2 Central & South America Therapeutic Nuclear Medicines Revenue by Countries 77
  • 9.4.3 Brazil 79

10 Middle East and Africa 80

• 10.1 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Type 81
• 10.2 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Application 82
• 10.3 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Countries 83
  • 10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries 83
  • 10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries 84
  • 10.3.3 Middle East 86
  • 10.3.4 Africa 87

11 Analysis of Therapeutic Nuclear Medicines Industry Key Manufacturers 88

• 11.1 Bayer 88
  • 11.1.1 Company Profile 88
  • 11.1.2 Product Information 89
  • 11.1.3 Sales, Price and Revenue 89
• 11.2 Novartis 90
  • 11.2.1 Company Profile 90
  • 11.2.2 Product Information 91
  • 11.2.3 Sales, Price and Revenue 91
• 11.3 China Isotope & Radiation 92
  • 11.3.1 Company Profile 92
  • 11.3.2 Product Information 93
  • 11.3.3 Sales, Price and Revenue 93
• 11.4 Dongcheng 94
  • 11.4.1 Company Profile 94
  • 11.4.2 Product Information 95
  • 11.4.3 Sales, Price and Revenue 95
• 11.5 Q BioMed 96
  • 11.5.1 Company Profile 96
  • 11.5.2 Product Information 97
  • 11.5.3 Sales, Price and Revenue 97
• 11.6 Curium Pharmaceuticals 98
  • 11.6.1 Company Profile 98
  • 11.6.2 Product Information 99
  • 11.6.3 Sales, Price and Revenue 99
• 11.7 Jubilant DraxImage 100
  • 11.7.1 Company Profile 100
  • 11.7.2 Product Information 101
  • 11.7.3 Sales, Price and Revenue 101
• 11.8 Lantheus 102
  • 11.8.1 Company Profile 102
  • 11.8.2 Product Information 103
  • 11.8.3 Sales, Price and Revenue 103
• 11.9 Spectrum Pharmaceuticals 104
  • 11.9.1 Company Profile 104
  • 11.9.2 Product Information 105
  • 11.9.3 Sales, Price and Revenue 105
• 11.10 Progenics Pharmaceuticals 106
  • 11.10.1 Company Profile 106
  • 11.10.2 Product Information 107
  • 11.10.3 Sales, Price and Revenue 107
• 11.11 International Isotopes 108
  • 11.11.1 Company Profile 108
  • 11.11.2 Product Information 109
  • 11.11.3 Sales, Price and Revenue 109

12 Value Chain and Sales Channels Analysis 111

• 12.1 Value Chain Analysis 111
• 12.2 Sales Channels Analysis 112
  • 12.2.1 Therapeutic Nuclear Medicines Sales Channels 112
  • 12.2.2 Therapeutic Nuclear Medicines Distributors 114
• 12.3 Therapeutic Nuclear Medicines Customers 116

13 Market Forecast 118

• 13.1 Global Therapeutic Nuclear Medicines Sales and Revenue Forecast 2019-2025 118
• 13.2 Global Therapeutic Nuclear Medicines Sales Forecast by Type 119
• 13.3 Global Therapeutic Nuclear Medicines Sales Forecast by Application 121
• 13.4 Therapeutic Nuclear Medicines Forecast by Regions 122
  • 13.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Regions2019-2025 122
  • 13.4.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions2019-2025 123
• 13.5 North America Market Forecast 124
  • 13.5.1 North America Therapeutic Nuclear Medicines Forecast by Countries 2019-2025 124
  • 13.5.2 United States 125
  • 13.5.3 Canada 126
  • 13.5.4 Mexico 126
• 13.6 Europe Market Forecast 127
  • 13.6.1 Europe Therapeutic Nuclear Medicines Forecast by Countries 2019-2025 127
  • 13.6.2 Germany 128
  • 13.6.3 France 129
  • 13.6.4 UK 129
  • 13.6.5 Italy 130
  • 13.6.6 Russia 130
• 13.7 Asia Pacific Market Forecast 131
  • 13.7.1 Asia Pacific Therapeutic Nuclear Medicines Sales Forecast by Countries 2019-2025 131
  • 13.7.2 China 132
  • 13.7.3 Japan 133
  • 13.7.4 Korea 133
  • 13.7.5 India 134
  • 13.7.6 Southeast Asia 134
• 13.8 Central & South America Market Forecast 135
  • 13.8.1 Central & South America Therapeutic Nuclear Medicines Sales Forecast by Countries 2019-2025 135
  • 13.8.2 Brazil 136
• 13.9 Middle East and Africa Market Forecast 137
  • 13.9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025 137
  • 13.9.2 Middle East 138
  • 13.9.3 Africa 139

14 Research Findings and Conclusion 140

15 Appendix 141

• 15.1 Research Methodology 141
  • 15.1.1 Methodology/Research Approach 141
  • 15.1.2 Data Source 145
• 15.2 Author Details 147
• 15.3 Disclaimer 148